Activities of dicationic compounds against Trichomonas vaginalis
- PMID: 15328138
- PMCID: PMC514753
- DOI: 10.1128/AAC.48.9.3602-3605.2004
Activities of dicationic compounds against Trichomonas vaginalis
Abstract
We evaluated 44 novel cationic compounds for activity against metronidazole-sensitive and -resistant Trichomonas vaginalis isolates. Six compounds in three different structural classes demonstrated 50% inhibitory concentrations as low as 1 microM against both sensitive and resistant isolates, suggesting a mode of action independent of parasite biochemical pathways that confer resistance to 5-nitroimidazoles.
Figures
Similar articles
-
A metronidazole-resistant strain of Trichomonas vaginalis and its sensitivity to Go 10213.J Antimicrob Chemother. 1984 Oct;14(4):423-6. doi: 10.1093/jac/14.4.423. J Antimicrob Chemother. 1984. PMID: 6334072
-
Resistance of Trichomonas vaginalis to metronidazole: report of the first three cases from Finland and optimization of in vitro susceptibility testing under various oxygen concentrations.J Clin Microbiol. 2000 Feb;38(2):763-7. doi: 10.1128/JCM.38.2.763-767.2000. J Clin Microbiol. 2000. PMID: 10655382 Free PMC article.
-
Activity of disulfiram (bis(diethylthiocarbamoyl)disulphide) and ditiocarb (diethyldithiocarbamate) against metronidazole-sensitive and -resistant Trichomonas vaginalis and Tritrichomonas foetus.J Antimicrob Chemother. 1998 Dec;42(6):817-20. doi: 10.1093/jac/42.6.817. J Antimicrob Chemother. 1998. PMID: 10052908
-
The modes of action of some anti-protozoal drugs.Parasitology. 1985 Apr;90 ( Pt 4):687-703. doi: 10.1017/s0031182000052318. Parasitology. 1985. PMID: 3892438 Review. No abstract available.
-
Persistent and recurrent Trichomonas vaginalis infections: epidemiology, treatment and management considerations.Expert Rev Anti Infect Ther. 2014 Jun;12(6):673-85. doi: 10.1586/14787210.2014.887440. Epub 2014 Feb 20. Expert Rev Anti Infect Ther. 2014. PMID: 24555561 Review.
Cited by
-
Trichomonas vaginalis: treatment questions and challenges.Expert Rev Anti Infect Ther. 2012 Feb;10(2):107-9. doi: 10.1586/eri.11.159. Expert Rev Anti Infect Ther. 2012. PMID: 22339182 Free PMC article. No abstract available.
-
Synthesis and Biophysical and Biological Studies of N-Phenylbenzamide Derivatives Targeting Kinetoplastid Parasites.J Med Chem. 2023 Oct 12;66(19):13452-13480. doi: 10.1021/acs.jmedchem.3c00697. Epub 2023 Sep 20. J Med Chem. 2023. PMID: 37729094 Free PMC article.
-
Drug library screening against metronidazole-sensitive and metronidazole-resistant Trichomonas vaginalis isolates.Sex Transm Infect. 2013 Sep;89(6):479-84. doi: 10.1136/sextrans-2013-051032. Epub 2013 Jun 22. Sex Transm Infect. 2013. PMID: 23794105 Free PMC article.
References
-
- Blagburn, B. L., K. L. Drain, T. M. Land, R. G. Kinard, P. H. Moore, D. S. Lindsay, D. A. Patrick, D. W. Boykin, and R. R. Tidwell. 1998. Comparative efficacy evaluation of dicationic carbazole compounds, nitrazoxanide, and paromomycin against Cryptosporidium parvum infections in a neonatal mouse model. Antimicrob. Agents Chemother. 42:2877-2882. - PMC - PubMed
-
- Boykin, D. W., A. Kumar, B. K. Bender, J. E. Hall, and R. R. Tidwell. 1996. Anti-pneumocystis activity of bis-amidoximes and bis-o-alkylamidoximes prodrugs. Bioorg. Med. Chem. Lett. 6:3017-3020.
-
- Boykin, D. W., A. Kumar, G. Xiao, W. D. Wilson, B. K. Bender, D. R. McCurdy, J. E. Hall, and R. R. Tidwell. 1998. 2,5-Bis-[4(N-alkylamidino)phenyl]furans as anti-Pneumocystis carinii agents. J. Med. Chem. 41:124-129. - PubMed
-
- Centers for Disease Control and Prevention. 1993. Sexually transmitted diseases treatment guidelines. Morb. Mortal. Wkly. Rep. 42(RR-14):70-72.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources